852
Views
55
CrossRef citations to date
0
Altmetric
Original Research

Development and optimization of solid lipid nanoparticle formulation for ophthalmic delivery of chloramphenicol using a Box-Behnken design

, , , , , & show all
Pages 683-692 | Published online: 06 Apr 2011

References

  • BadawiAEl-LaithyHEl QidraREl MoftyHEl dallyMChitosan based nanocarriers for indomethacin ocular deliveryArch Pharm Res20083181040104918787795
  • De JongWBormPDrug delivery and nanoparticles: applications and hazardsInt J Nanomedicine20083213314918686775
  • ÜnerMYenerGImportance of solid lipid nanoparticles (SLN) in various administration routes and future perspectivesInt J Nanomedicine20072328930018019829
  • FreitasCMüllerRCorrelation between long-term stability of solid lipid nanoparticles (SLN (TM)) and crystallinity of the lipid phaseEur J Pharm Biopharm199947212513210234536
  • MüllerRRühlDRungeSSchulze-ForsterKMehnertWCytotoxicity of solid lipid nanoparticles as a function of the lipid matrix and the surfactantPharm Res19971444584629144731
  • HuangZHuaSYangYFangJDevelopment and evaluation of lipid nanoparticles for camptothecin delivery: a comparison of solid lipid nanoparticles, nanostructured lipid carriers, and lipid emulsionActa Pharmacologica Sinica20082991094110218718178
  • MüllerRMäderKGohlaSSolid lipid nanoparticles (SLN) for controlled drug delivery-a review of the state of the artEuropean Journal of Pharmaceutics and Biopharmaceutics200050116117710840199
  • AraiHSuzukiTKasedaCTakayamaKEffect of an Experimental Design for Evaluating the Nonlinear Optimal Formulation of Theophylline Tablets Using a Bootstrap Resampling TechniqueChem Pharm Bull200957657257919483336
  • El-MalahYNazzalSKhanfarND-optimal mixture design: optimization of ternary matrix blends for controlled zero-order drug release from oral dosage formsDrug Dev Ind Pharm200632101207121817090443
  • BozkirASakaOFormulation and investigation of 5-FU nanoparticles with factorial design-based studiesIl Farmaco2005601084084616087183
  • BhavsarMTiwariSAmijiMFormulation optimization for the nanoparticles-in-microsphere hybrid oral delivery system using factorial designJ Control Release2006110242243016338017
  • DerakhshandehKErfanMDadashzadehSEncapsulation of 9-nitrocamptothecin, a novel anticancer drug, in biodegradable nanoparticles: factorial design, characterization and release kineticsEur J Pharm Biopharm2007661344117070678
  • GohelMAminAFormulation optimization of controlled release diclofenac sodium microspheres using factorial designJ Control Release1998512–31151229685908
  • NazzalSKhanMResponse surface methodology for the optimization of ubiquinone self-nanoemulsified drug delivery systemAAPS PharmSciTech2002312331
  • ChangJHuangYHouSWangRWuPTsaiYFormulation optimization of meloxicam sodium gel using response surface methodologyInt J Pharm20073381–2485417360134
  • LiuCWuCFangJCharacterization and formulation optimization of solid lipid nanoparticles in vitamin K1 deliveryDrug Dev Ind Pharm201036775176120136495
  • ManjunathKReddyJVenkateswarluVSolid lipid nanoparticles as drug delivery systemsMethods Find Exp Clin Pharmacol200527212714415834465
  • YuanHWangLDuYYouJHuFZengSPreparation and characteristics of nanostructured lipid carriers for control-releasing progesterone by melt-emulsificationColloids Surf B: Biointerfaces200760217417917656075
  • YangCZhaoXHuHPreparation, Optimization and Characteristic of Huperzine A Loaded Nanostructured Lipid CarriersChem Pharm Bull201058565666120460792
  • BottariFDi ColoGNannipieriESaettoneMSerafiniMInfluence of drug concentration on in vitro release of salicylic acid from ointment basesJ Pharm Sci19746311177917834427246
  • MyersRMontgomeryDAnderson-CookCResponse surface methodology: process and product optimization using designed experimentsNew YorkJohn Wiley & Sons2009
  • WoitiskiCVeigaFRibeiroANeufeldRDesign for optimization of nanoparticles integrating biomaterials for orally dosed insulinEur J Pharm Biopharm2009731253319508892
  • RahmanZZidanAHabibMKhanMUnderstanding the quality of protein loaded PLGA nanoparticles variability by Plackett-Burman designInt J Pharm20103891–218619420038446
  • ShahMPathakKDevelopment and Statistical Optimization of Solid Lipid Nanoparticles of Simvastatin by Using 2 3 Full-Factorial DesignAAPS PharmSciTech20101821152999
  • YangYChungTBaiXChanWEffect of preparation conditions on morphology and release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion methodChem Eng Sci2000551222232236
  • SchubertMMüller-GoymannCSolvent injection as a new approach for manufacturing lipid nanoparticles-evaluation of the method and process parametersEur J Pharm Biopharm200355112513112551713
  • LerouxJAllémannEDoelkerEGurnyRNew approach for the preparation of nanoparticles by an emulsification-diffusion methodEur J Pharm Biopharm19954111418
  • SchwarzCMehnertWLucksJMüllerRSolid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterization and sterilizationJ Control Release19943018396
  • GullapalliRShethBInfluence of an optimized non-ionic emulsifier blend on properties of oil-in-water emulsionsEur J Pharm Biopharm199948323323810612034
  • PeppasNASahlinJJA simple equation for the description of solute release. III. Coupling of diffusion and relaxationInt J Pharm1989572169172